Olanzapine/fluoxetine
< Olanzapine
| Combination of | |
|---|---|
| Olanzapine | Atypical antipsychotic |
| Fluoxetine | Selective serotonin reuptake inhibitor |
| Clinical data | |
| Trade names | Symbyax, Cinol Forte, Olapin Forte, others |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| KEGG | |
| (what is this?) (verify) | |
Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI). Olanzapine/fluoxetine is primarily used to treat the depressive episodes of bipolar I disorder as well as treatment-resistant depression.